Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Differential Bio is a Munich-based biotechnology company specializing in the optimization of microbial fermentation and bioprocesses through a combination of robotic lab automation and artificial intelligence. The company's core offering is a Virtual Scale-up Platform that utilizes AI-driven digital twins to simulate microbial behavior under a wide spectrum of industrial conditions, significantly reducing the time and cost associated with traditional wet-lab experimentation. By mimicking large-scale stress factors in a microliter-scale environment, Differential Bio enables bio-manufacturers to predict optimal growth conditions and key performance indicators (KPIs) with high accuracy. The company aims to become a standard for in silico bioprocess optimization, supporting the bioeconomy from early-stage R&D through to large-scale production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Differential Dynamics.